Cargando…

Haemodynamic effects of levosimendan in advanced but stable chronic heart failure

AIMS: Levosimendan improves haemodynamics in acute decompensated heart failure (HF). However, it is increasingly used for repetitive or intermittent infusions in advanced but stable chronic HF, without clear indication, selection criteria, or effect. We tested the hypotheses that (1) levosimendan im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Najjar, Emil, Stålhberg, Marcus, Hage, Camilla, Ottenblad, Erica, Manouras, Aristomenis, Haugen Löfman, Ida, Lund, Lars H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933961/ https://www.ncbi.nlm.nih.gov/pubmed/29469177 http://dx.doi.org/10.1002/ehf2.12272

Ejemplares similares

Left atrial strain improves estimation of filling pressures in heart failure: a simultaneous echocardiographic and invasive haemodynamic study
por: Lundberg, Anders, et al.
Publicado: (2018)

Association between central haemodynamics and renal function in advanced heart failure: a nationwide study from Sweden
por: Bobbio, Emanuele, et al.
Publicado: (2022)

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019)

Effect of β-blockade on the haemodynamic responses of levosimendan and dobutamine in the treatment of low-output heart failure
por: Follath, F, et al.
Publicado: (2002)

Doppler estimates of pulmonary vascular resistance to phenotype pulmonary hypertension in heart failure
por: Venkateshvaran, Ashwin, et al.
Publicado: (2019)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

The anti-inflammatory and haemodynamic effects of levosimendan on advanced heart failure patients: a meta-analysis of published studies
por: Zhou, Suzhen, et al.
Publicado: (2023)

Prevalence and prognostic impact of kidney disease on heart failure patients
por: Löfman, Ida, et al.
Publicado: (2016)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
por: Löfman, Ida, et al.
Publicado: (2018)

Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002)

A review of levosimendan in the treatment of heart failure
por: Kasikcioglu, Hulya Akhan, et al.
Publicado: (2006)

Levosimendan in pulmonary hypertension and right heart failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)

A case report about successful treatment of refractory ventricular tachycardia with ablation under prolonged haemodynamic support with extracorporeal membrane oxygenation
por: Najjar, Emil, et al.
Publicado: (2021)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

Uric acid in advanced heart failure: relation to central haemodynamics and outcome
por: Deis, Tania, et al.
Publicado: (2022)

Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure
por: Lilleberg, J, et al.
Publicado: (2002)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure
por: Delgado, Juan F., et al.
Publicado: (2017)

Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction
por: Löfström, Ulrika, et al.
Publicado: (2019)

Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcome
por: Deis, Tania, et al.
Publicado: (2019)

Efficiency and Safety of Prolonged Levosimendan Infusion in Patients with Acute Heart Failure
por: Aidonidis, Georgios, et al.
Publicado: (2011)

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure
por: Zima, E, et al.
Publicado: (2007)

Preoperative optimization with levosimendan in heart failure patient undergoing thoracic surgery
por: Nespoli, Moana Rossella, et al.
Publicado: (2016)

Levosimendan improves exercise performance in patients with advanced chronic heart failure
por: Mushtaq, Saima, et al.
Publicado: (2015)

The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
por: Nieminen, Markku S., et al.
Publicado: (2017)

The inodilator levosimendan as a treatment for acute heart failure in various settings
por: Gustafsson, Finn, et al.
Publicado: (2017)

Levosimendan in acute and advanced heart failure: still some chapters to be written
por: Pölzl, Gerhard
Publicado: (2018)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Effects of Levosimendan on cardiac function, size and strain in heart failure patients
por: Beitzke, D., et al.
Publicado: (2020)

Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies
por: Glinka, Lidia, et al.
Publicado: (2019)

Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap
por: Conti, Nicolina, et al.
Publicado: (2021)

Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Optimizing diastolic pressure gradient assessment
por: Manouras, Aristomenis, et al.
Publicado: (2020)

Haemodynamic effects of sacubitril/valsartan in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2022)

Haemodynamic determinants of quality of life in chronic heart failure
por: Fatrin, Serlie, et al.
Publicado: (2022)

Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients
por: Zhang, Dengqing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m4mteoecpvrfp8cur4e1h8s893